Among lncRNAs, DNAJC3-AS1 was first discovered in clinical, cisplatin-resistant osteosarcomas to interact with the host gene DNAJC3, regulating the cisplatin sensitivity of the cells and resulting in tumors resistant to cisplatin [19]. This evidence concerns the gene DNAJC3 and osteosarcoma.